Cargando…

Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study

Background: Efavirenz (EFV) is widely used in antiretroviral therapy (ART), but the incidence and risk factors of neuropsychiatric adverse events (NPAEs) after EFV treatment have rarely been studied in Chinese ART naïve patients. Methods: This prospective cohort study assessed HIV-infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Wei, Wang, Sen, Wang, Xi, Shao, Ying, Wang, Yali, Ye, Jiangzhu, Su, Bin, Jiang, Taiyi, Zhang, Tong, Wu, Hao, Liu, An, Li, Qunhui, Mahajan, Supriya D., Li, Zaicun, Sun, Lijun, Dai, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943719/ https://www.ncbi.nlm.nih.gov/pubmed/33716807 http://dx.doi.org/10.3389/fpsyt.2021.579448

Ejemplares similares

The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
por: Stellbrink, HJ, et al.
Publicado: (2010)

Efavirenz and neuropsychiatric effects
por: Dheda, Mukesh
Publicado: (2017)

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China
por: Su, Bin, et al.
Publicado: (2019)

Effect of a multi-dimensional case management model on anti-retroviral therapy-related outcomes among people living with human immunodeficiency virus in Beijing, China
por: Dai, Lili, et al.
Publicado: (2020)

Incidence of neuropsychiatric side effects of efavirenz in HIV-positive treatment-naïve patients in public-sector clinics in the Eastern Cape
por: Gaida, Razia, et al.
Publicado: (2016)

Is PrEP necessary during natural conception in HIV-1-serodiscordant couples on ART with suppressed viral load? A retrospective cohort analysis
por: Sun, Lijun, et al.
Publicado: (2020)

1033. One year of Bictegravir in Mexico City: Differences in the Neuropsychiatric Adverse Events vs. Efavirenz
por: Rodriguez, Victor
Publicado: (2020)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz
por: Drury, Andrew, et al.
Publicado: (2018)

Abnormal Default Mode Network Homogeneity in Treatment-Naive Patients With First-Episode Depression
por: Gao, Yujun, et al.
Publicado: (2018)

Natural Conception May Be an Acceptable Option in HIV-Serodiscordant Couples in Resource Limited Settings
por: Sun, Lijun, et al.
Publicado: (2015)

Altered Structural Covariance Among the Dorsolateral Prefrontal Cortex and Amygdala in Treatment-Naïve Patients With Major Depressive Disorder
por: Zuo, Zhiwei, et al.
Publicado: (2018)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
por: Cross, Amy, et al.
Publicado: (2021)

Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy
por: Zong, Xiaofen, et al.
Publicado: (2023)

Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions
por: Simonetti, Alessio, et al.
Publicado: (2020)

Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations
por: Chen, Jing-Xu, et al.
Publicado: (2019)

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal
por: Canestri, Anna, et al.
Publicado: (2007)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Bibliometric Analysis of Quantitative Electroencephalogram Research in Neuropsychiatric Disorders From 2000 to 2021
por: Yao, Shun, et al.
Publicado: (2022)

Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease
por: Li, Xi, et al.
Publicado: (2022)

Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication or Cognitive-Behavior Therapy in Treatment-Naive Depression
por: Tai, Hua-Hsin, et al.
Publicado: (2021)

Editorial: Emotional Disturbance and Brain Imaging in Neuropsychiatric Disorders
por: Esposito, Roberto, et al.
Publicado: (2021)

International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders
por: Palagini, Laura, et al.
Publicado: (2021)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Enhanced Connectivity of Thalamo-Cortical Networks in First-Episode, Treatment-Naive Somatization Disorder
por: Zhao, Jin, et al.
Publicado: (2020)

Posttraumatic Stress Disorder and Nonadherence to Treatment in People Living With HIV: A Systematic Review and Meta-analysis
por: Hou, Jianhua, et al.
Publicado: (2020)

Perspectives of healthcare professionals of the neuropsychiatric side effects associated with efavirenz and its management
por: Gaida, Razia, et al.
Publicado: (2018)

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings
por: Cooper, David A., et al.
Publicado: (2014)

Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia
por: Wu, Renrong, et al.
Publicado: (2019)

Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
por: Xu, Ling, et al.
Publicado: (2021)

Editorial: Neuroimaging insights into the link between sleep disturbances and neuropsychiatric disorders
por: von Deneen, Karen M., et al.
Publicado: (2023)

Abnormal Brain Network Interaction Associated With Positive Symptoms in Drug-Naive Patients With First-Episode Schizophrenia
por: Yuan, Liu, et al.
Publicado: (2022)

New Challenges and Frontiers in the Research for Neuropsychiatric Disorders
por: Tropea, Daniela
Publicado: (2012)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Editorial: Neurological Soft Signs in Neuropsychiatric Conditions
por: Toro, Pablo, et al.
Publicado: (2019)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vt018c0fgv6t4amlgjvja7omtb